Researchers at Yale School of Public Health, GHLI Receive Funding from Gates Foundation for Global Projects
Researchers at the Yale School of Public Health and the Yale Global Health Leadership Initiative, in collaboration with international peers, have received Grand Challenges Explorations grants from the Bill & Melinda Gates Foundation for innovative research.
Antiretroviral Therapy Crucial in Preventing non-Hodgkin Lymphoma, YSPH Study Reinforces
A research team led by the Yale School of Public Health has found that for people living with HIV/AIDS, both recent immunosuppression and prolonged HIV viremia play important and independent roles in the development of non-Hodgkin lymphoma.
Videogame boosts sex health IQ and attitudes in minority teens
A videogame designed by Yale researchers to promote health and reduce risky behavior in teens improves sexual health knowledge and attitudes among minority youth, according to a new study. The findings validate the value of the videogame as a tool to engage and educate teens at risk for HIV and other sexually transmitted infections (STIs), said the researchers.
Cutbacks in Foreign Aid for HIV Treatment Would Cause Great Harm, Generate Few Savings
Proposed reductions in U.S. foreign aid would have a devastating impact on HIV treatment and prevention programs in countries receiving such aid, an international team of investigators reports. In their paper published online in Annals of Internal Medicine, the team led by researchers at Massachusetts General Hospital (MGH) and the Yale School of Public Health describes how a 33 percent cutback in funds earmarked for HIV/AIDS prevention, treatment and research in recent budget proposals would only save $900 per year of life lost in the countries of South Africa and Côte d’Ivoire.
Life expectancy for HIV patients has increased by 10 years in U.S. and Europe
Life expectancy for 20-year-olds initiating treatment for HIV has increased by about a decade in the European Union and North America since the introduction of antiretroviral therapy in the mid-1990s, according to a study co-authored by Yale researcher Dr. Amy Justice and published in The Lancet HIV. The increases are among treated individuals compared with untreated individuals, the global team of researchers said.
New U.N. targets for HIV/AIDS treatment expensive, but could save millions of lives
A new study estimates the impact of an initiative of the Joint United Nations Programme on HIV/AIDS known as 90-90-90, and finds that while its targets for HIV testing and treatment will require unprecedented investment, it will increase survival, reduce the number of children orphaned by HIV, and contain the global AIDS epidemic.
Improved Sanitation May Reduce Both Sexual Violence and Costs in South African Townships, Study Finds
Improving access to public toilets in South African urban settlements may reduce both the incidence of sexual assaults by nearly 30 percent and the overall cost to society, a study by researchers at the Yale schools of public health and management found.
Emergency department treatment for opioid addiction better than referrals
Yale researchers conducted the first known randomized trial comparing three treatment strategies for opioid-dependent patients receiving emergency care. They found that patients given the medication buprenorphine were more likely to engage in addiction treatment and reduce their illicit opioid use.
Home HIV Testing: Good News but Not a Game Changer
On 3 July 2012, the U.S. Food and Drug Administration (FDA) approved the OraQuick In-Home HIV Test (OraSure Technologies, Bethlehem, Pennsylvania) to detect antibodies to HIV types 1 and 2. This test will soon be available for sale both online and at more than 30 000 retail outlets nationwide. This is the first truly over-the-counter home HIV testing kit, the same test that professionals have used in health care and community-based settings since its approval in 2004.